BioHealth Management, LLC

Sample Engagements

Therapeutics
- Completed due diligence and assessment of infectious disease, inflammation and cancer portfolio in publicly traded companies. Advised investment bank on acquiring larger positions in companies.
- Created product and market strategy for early stage start-up in inflammation area including financing documents.
- Participated in investor meetings resulting in financing from large biopharmaceutical and venture capitalist groups.
Diagnostics and Devices
- Created business and market strategy leading to 3 rounds of investment from angels, venture capitalists, and investment bank. Company is cash flow positive.
- Finance and market strategy for venture backed technology company with applications in diagnostics. Refined plan and identified multiple partners and sources of financing.

Therapeutics
- Identified new market opportunity for therapeutic in gastritis from publicly traded company. Investigated opportunities, contacted potential partners and participated in meetings. Company decision not to out-license but to develop internally.
- Developed marketing materials and identified partners for anti-infective product with large market opportunity. Met with biopharmaceutical companies and received term sheets.

Diagnostics and Devices
- Developed marketing materials and identified partners for diagnostic biomarker to manage patients with Hepatitis C. Partners identified and agreed on terms.
- Developed clinical applications and marketing strategy for platform technology in infectious disease and cancer. Identified partners and participated in discussions.

Therapeutics
- Developed and implemented portfolio strategy for publicly traded oncology company. Brought in expert focus group and re-prioritized portfolio creating new financing opportunity.
- Developed strategy for anti-fungal company to move into anti-bacterial market. Based on new market direction, company merged with partner in $100 M buy-out.

Diagnostics and Devices
- Managed market evaluation and portfolio development through mergers and acquisitions for publicly traded company expanding from devices into therapeutic space. Company merged with therapeutics company.
- Finance and market strategy for company with medical device for inflammatory bowel disease fistulas. Venture consortium formed and company entered Phase III.

Bioinformatics Area
- Developed market and financing strategy for bioinformatics company with focus in clinical trial management. New strategy led to increased investment and purchase by larger company.
- International sales and market plan for new healthcare services company. Plan rolling out.

Therapeutics
- Successful pre-clinical strategy including new market indication through successful IND.
- Successful clinical trial for phase I/II therapeutic in inflammatory bowel disease.
- Successful orphan drug applications in the USA and support for EMEA applications.

Devices and Diagnostics
- Achieved first FDA approved products from division of large biopharmaceutical company. In charge of process including regulatory, clinical and marketing from bench to commercialization.
- Achieved first FDA approved products from company. In charge of process including regulatory, clinical, and marketing from bench to commercialization.

Analyzed translational projects from university medical center. Defined and implemented steps for intellectual property protection, licensing, and global partnering.

Planned and participated in two-day workshop to prepare international companies for partnering meetings in the USA. Created program and meetings with venture capitalists, investment banks, and corporate partners.